Any surprises from selective oestrogen-receptor modulators?

被引：0
|
作者：
V. Craig Jordan
机构：
[1] Georgetown Lombardi Comprehensive Cancer Center,
[2] Oncology,undefined
来源：
Nature Reviews Clinical Oncology | 2013年 / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The marriage of medicinal chemistry, molecular biology and medicine is perhaps best exemplified by the evolution of selective oestrogen-receptor modulators (SERMs). Translational studies might be useful for predicting the myriad clinical responses to SERMs, contributing to improvements in women's health.
引用
收藏
页码：432 / 434
页数：2
相关论文
共 50 条
  • [41] Molecular classification of selective oestrogen receptor modulators on the basis of gene expression profiles of breast cancer cells expressing oestrogen receptor α
    A S Levenson
    I L Kliakhandler
    K M Svoboda
    K M Pease
    S A Kaiser
    J E Ward, III
    V C Jordan
    British Journal of Cancer, 2002, 87 : 449 - 456
  • [42] Molecular classification of selective oestrogen receptor modulators on the basis of gene expression profiles of breast cancer cells expressing oestrogen receptor α
    Levenson, AS
    Kliakhandler, IL
    Svoboda, KM
    Pease, KM
    Kaiser, SA
    Ward, JE
    Jordan, VC
    BRITISH JOURNAL OF CANCER, 2002, 87 (04) : 449 - 456
  • [43] The association of androgen- and oestrogen-receptor gene polymorphisms with urolithiasis in men
    Chen, WC
    Wu, HC
    Lin, WC
    Wu, MC
    Hsu, CD
    Tsai, FJ
    BJU INTERNATIONAL, 2001, 88 (04) : 432 - 436
  • [44] Successful translation research with selective oestrogen receptor modulators to treat and prevent breast cancer
    Jordan, V. Craig
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2007, 67 (05) : 443 - 450
  • [45] Anatomically-Specific Actions of Oestrogen Receptor in the Developing Female Rat Brain: Effects of Oestradiol and Selective Oestrogen Receptor Modulators on Progestin Receptor Expression
    Gonzales, K. L.
    Quadros-Mennella, P.
    Tetel, M. J.
    Wagner, C. K.
    JOURNAL OF NEUROENDOCRINOLOGY, 2012, 24 (02) : 285 - 291
  • [46] Antiresorptive Drugs Beyond Bisphosphonates and Selective Oestrogen Receptor Modulators for the Management of Postmenopausal Osteoporosis
    Reginster, J. Y.
    Neuprez, A.
    Beaudart, C.
    Lecart, M. P.
    Sarlet, N.
    Bernard, D.
    Disteche, S.
    Bruyere, O.
    DRUGS & AGING, 2014, 31 (06) : 413 - 424
  • [47] Clinically used selective oestrogen receptor modulators increase LDL receptor activity in primary human lymphocytes
    Cerrato, F.
    Fernandez-Suarez, M. E.
    Alonso, R.
    Alonso, M.
    Vazquez, C.
    Pastor, O.
    Mata, P.
    Lasuncion, M. A.
    Gomez-Coronado, D.
    BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (05) : 1379 - 1394
  • [48] Antiresorptive Drugs Beyond Bisphosphonates and Selective Oestrogen Receptor Modulators for the Management of Postmenopausal Osteoporosis
    J. Y. Reginster
    A. Neuprez
    C. Beaudart
    M. P. Lecart
    N. Sarlet
    D. Bernard
    S. Disteche
    O. Bruyere
    Drugs & Aging, 2014, 31 : 413 - 424
  • [49] An immunohistochemical characterization of oestrogen-receptor negative ductal carcinoma in-situ of the breast
    Baqai, T
    Peston, D
    Shousha, S
    JOURNAL OF PATHOLOGY, 2000, 192 : 20A - 20A
  • [50] Association between the progesterone receptor and HER 2/neu in oestrogen-receptor positive breast cancer
    不详
    EJC SUPPLEMENTS, 2004, 2 (09): : 90 - 90
12345